Evaxion Biotech AS (EVAX)
1.49
+0.12
(+8.76%)
USD |
NASDAQ |
Nov 22, 16:00
1.42
-0.07
(-4.70%)
After-Hours: 20:00
Evaxion Biotech Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | -5.19M |
| March 31, 2022 | -8.186M |
| December 31, 2021 | -4.115M |
| September 30, 2021 | -6.295M |
| June 30, 2021 | -7.488M |
| Date | Value |
|---|---|
| March 31, 2021 | -4.035M |
| December 31, 2020 | -4.42M |
| September 30, 2020 | -2.765M |
| June 30, 2020 | -2.303M |
| March 31, 2020 | -2.95M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.186M
Minimum
Mar 2022
-2.303M
Maximum
Jun 2020
-4.775M
Average
-4.268M
Median
Cash from Operations (Quarterly) Benchmarks
| Ascendis Pharma AS | -- |
| DBV Technologies SA | -22.46M |
| Adaptimmune Therapeutics PLC | -54.45M |
| Akari Therapeutics PLC | -1.49M |
| Biodexa Pharmaceuticals PLC | -- |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow Yield | -361.0% |